Erfan Wei
Beijing, 100081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Sildenafil suppresses osteoporosis-related bone marrow adiposity by inhibiting Adipogenic differentiation of mesenchymal stem cells.
Journal: Cellular signalling
Published: December 26, 2025
Orchestrated Engineered Polyphenol-Peptide Condensates Coupled With β-GP Reverses Diabetic Osteoporosis by Remodeling Mitophagy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 27, 2025
ATP-modulatory biomaterials: Design strategies and medical applications.
Journal: Biomaterials
Published: October 20, 2025
IRF1 regulates apoptosis and osteogenic differentiation of bone marrow mesenchymal stem cells and ameliorates osteoporosis by activating the PI3K/AKT signaling pathway.
Journal: Journal of advanced research
Published: May 22, 2025
Biomedical Applications of Gadolinium-Containing Biomaterials: Not Only MRI Contrast Agent.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 26, 2025
Antisenescence therapies for age-related bone loss: Target factors, medicines, biomedical materials.
Antisenescence therapies for age-related bone loss: Target factors, medicines, biomedical materials.
Journal: Clinical and translational medicine
Published: December 29, 2024
Sildenafil promotes osteogenic differentiation of human mesenchymal stem cells and inhibits bone loss by affecting the TGF-β signaling pathway.
Journal: Stem cell research & therapy
Published: December 21, 2024
TGF-β signaling regulates differentiation of MSCs in bone metabolism: disputes among viewpoints.
Journal: Stem cell research & therapy
Published: November 07, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026